Akouos
Boston
About Akouos
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $162.5M
- Funding stage: M&A
- Last round: Series B (Mar 2020)
- Ticker: nasdaq:AKUS
- Website: akouos.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/akouos-92580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.